Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".
Kikuchi T, Takeuchi Y, Nouso K, Kariyama K, Kuwaki K, Toshimori J, Iwado S, Moriya A, Hagihara H, Takabatake H, Tada T, Yasunaka T, Sakata M, Sue M, Miyake N, Adachi T, Wada N, Onishi H, Shiraha H, Takaki A, Otsuka M. Kikuchi T, et al. Among authors: wada n. Liver Int. 2024 May 8. doi: 10.1111/liv.15964. Online ahead of print. Liver Int. 2024. PMID: 38717049 No abstract available.
Investigation of the impact of COVID-19 on postoperative outcomes using a nationwide Japanese database of patients undergoing laparoscopic distal gastrectomy and low anterior resection for gastric cancer and rectal cancer.
Akagi T, Endo H, Inomata M, Shiroshita H, Yamaguchi S, Eguchi S, Wada N, Kurokawa Y, Seki Y, Sakai Y, Yamamoto H, Kakeji Y, Kitagawa Y, Taketomi A, Mori M. Akagi T, et al. Among authors: wada n. Ann Gastroenterol Surg. 2024 Jan 28;8(3):521-529. doi: 10.1002/ags3.12776. eCollection 2024 May. Ann Gastroenterol Surg. 2024. PMID: 38707231 Free PMC article.
Carbon monoxide-loaded cell therapy as an exercise mimetic for sarcopenia treatment.
Noguchi I, Maeda H, Kobayashi K, Nagasaki T, Kato H, Yanagisawa H, Wada N, Kanazawa G, Kaji T, Sakai H, Fujimaki S, Ono Y, Taguchi K, Chuang VTG, Saruwatari J, Otagiri M, Watanabe H, Maruyama T. Noguchi I, et al. Among authors: wada n. Free Radic Biol Med. 2024 Apr 23;220:67-77. doi: 10.1016/j.freeradbiomed.2024.04.231. Online ahead of print. Free Radic Biol Med. 2024. PMID: 38657755
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab.
Kikuchi T, Takeuchi Y, Nouso K, Kariyama K, Kuwaki K, Toshimori J, Iwado S, Moriya A, Hagihara H, Takabatake H, Tada T, Yasunaka T, Sakata M, Sue M, Miyake N, Adachi T, Wada N, Onishi H, Shiraha H, Takaki A, Otsuka M. Kikuchi T, et al. Among authors: wada n. Liver Int. 2024 Mar 15. doi: 10.1111/liv.15907. Online ahead of print. Liver Int. 2024. PMID: 38488749
1,535 results